Now, more than ever, the biotech sector is booming — flooding the stock market with stocks to buy.
Every October kicks off a string of major biotech conferences… Not only in the U.S. but across the world.
Twenty-one different conferences are slotted over the next four weeks in the U.S. alone. Hundreds of biotech and big pharmacy companies from all over are going to showcase big developments, medical breakthroughs, clinical trial results, new drug applications and more.
It’s no wonder it’s a favorite time of the year among traders!
Price movements during October and November can be much more sensitive to this data and all the new announcements as there can be a lot of buildup and fanfare over which biotech stocks to buy.
All of these things can act as a catalyst to drive the stock price of these biotech companies up. That means that now is the time to buy biotech stocks while things are still heating up in the stock market.
Forbes has even stated that it’s not uncommon for biotech stocks to jump 200% in one day.
Take bluebird bio (Nasdaq: BLUE) for example: The company presented at the Piper Jaffray Annual Healthcare Conference on November 29, 2016.
The biotech company focuses on gene editing. At the time, bluebird was working through phase two and three of study for a drug called Lenti-D. Following the presentation, shares surged from around $50 to $230 over the next year
This year, the stock market is picking up on two more biotech stocks that have been surging in October and look to have major upside in them this coming November…
It’s officially October and I couldn’t be more excited…
Most traders don’t know this, but every year a small yet profitable trading window opens up in the fall…
It allows investors to turn just a few hundred bucks into what could be a couple thousand — especially since the string of major biotech conferences has officially begun, supplying the stock market with catalyst after catalyst.
And if these stocks are played the right way…It can be incredibly lucrative for people like us.
It’s already happened with Trillium Therapeutics (Nasdaq: TRIL) and Ocular Therapeutix (Nasdaq: OCUL).
With these babies in my account, I’ve been hitting 52-week highs everyday this week.
These two biotech stocks have been outperforming every expectation I had when I recommended them to my Free Riders Club. And they keep surprising me…
These trades have gone up 20% and 50% — in a couple of days! And traders didn’t even have to risk a single penny of their starting capital.
And I have even more good news about OCUL that I’ll explain in my video…
Do you like trading biotech stocks? Which names are your favorite? Have you ever traded either of the tickers I gave away in today’s video? Share your thoughts in the comment section below.
P.S. I can’t stop thinking about my most recent trades in my Free Riders Club program…
And there is still time for you to get in on these trades.